Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-15 5:06 pm Unchanged | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,885,533 10.5% | 0 (Unchanged) | View |
| 2022-04-21 4:30 pm Purchase | 13D | Inmune Bio Inc. INMB | Moss David J | 1,882,956 10.1% | 226,206 (+13.65%) | View |
| 2022-04-21 4:30 pm Purchase | 13D | Inmune Bio Inc. INMB | Lowdell Mark William | 2,046,383 11.1% | 120,132 (+6.24%) | View |
| 2022-04-21 4:30 pm Purchase | 13D | Inmune Bio Inc. INMB | Tesi Raymond Joseph | 2,155,403 11.6% | 181,137 (+9.17%) | View |
| 2022-02-14 06:09 am Sale | 13G | Inmune Bio Inc. INMB | Altium Capital Management LP | 0 0% | -909,091 (Position Closed) | View |
| 2022-02-10 12:40 pm Purchase | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,885,533 10.6% | 194,533 (+11.50%) | View |
| 2021-07-19 09:25 am Purchase | 13G | Inmune Bio Inc. INMB | Altium Capital Management LP | 909,091 5.1% | 909,091 (New Position) | View |
| 2021-01-22 5:01 pm Purchase | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,691,000 12.5% | 36,000 (+2.18%) | View |
| 2020-02-14 4:43 pm Purchase | 13D | Inmune Bio Inc. INMB | Tesi Raymond Joseph | 1,974,266 17.66% | 158,433 (+8.73%) | View |
| 2020-02-14 4:42 pm Purchase | 13D | Inmune Bio Inc. INMB | Moss David J | 1,656,750 14.82% | 151,335 (+10.05%) | View |
| 2020-02-14 4:42 pm Purchase | 13D | Inmune Bio Inc. INMB | Lowdell Mark William | 1,926,251 17.25% | 172,928 (+9.86%) | View |
| 2020-02-14 10:49 am Purchase | 13G | Inmune Bio Inc. INMB | Xencor Inc XNCR | 1,655,000 15.3% | 1,655,000 (New Position) | View |
| 2019-06-10 5:28 pm Purchase | 13G | Inmune Bio Inc. INMB | Toucan Capital Fund III L.P. | 1,130,000 11.08% | 430,000 (+61.43%) | View |